Neo Ivy Capital Management disclosed a new holding in Hanesbrands ( HBI +2.41%), acquiring 627,098 shares valued at $4.13 ...

What would happen if every Australian had a guaranteed income? Policy experts say it’s no longer a utopian idea but a ...

SAN MATEO, Calif., Nov. 12, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way to find the ...

The company reported basic and diluted earnings per share of fils 48 for Q3 2025 versus fils 39 for the same period in 2024 ...

Heartflow expects total revenue for the full year 2025 to be in the range of $173.0 million to $173.5 million, representing year-over-year growth of approximately 37.5% to 38.0%.

For the third quarter of 2025, Ascendis Pharma reported a net loss of €61.0 million, or €1.00 per share basic and diluted ...

Journey Medical Corporation ( DERM) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's Third Quarter ...

Corby Spirit and Wine Limited (“Corby” or the “Company”) (TSX: CSW.A) (TSX: CSW.B), a leading Canadian manufacturer, marketer and importer of spirits, wines and ...

Vertex Resource Group Ltd. (“Vertex” or the “Company”) reports its financial and operational results for the third quarter ...

Third quarter 2025 GAAP net loss of $(12.5) million or $(0.57) per basic weighted average common share and Distributable Earnings(1) of $3.5 million or $0.16 per basic weighted average common share ...